The VisioLite® laser is an Er:YAG laser in the mid-infrared (IR) wavelength 2940nm. The VisioLite® has particular advantages over the UV lasers and other existing systems in the market. The unique features of include:
Compact design for ease of use and convenience in a clinical setting
Flexibility and Control of operation at high repetition rates (for fast procedures) and at a short pulse width (for reduced thermal effects) adding value in safety and precision
The Er:YAG wavelength matches that of the tissue (water) absorption peak making it a more effective tool for precise tissue ablation and accurate vision correction
The Er:YAG wavelength eliminates the potential risk of mutanagenic side effects which may be a concern in UV lasers
The Laser Tissue interaction at 2.94um is superior to any other wavelength since 95% connective tissue is comprised primarily of WATER
Unlike other lasers at different wavelengths, the VisioLite® laser essentially vaporizes the water out of the tissue without significant thermal side effects and has these advantages in Laser Tissue interaction:
o 10-20X better absorbed by water than CO2 at 10.6um
o 3X better absorbed by water than Er:YSGG at 2.79um
o Ablation threshold for water at 2.94um about 1 J/cm2
o The ablation occurs instantly and is a surface effect only.
The VisioLite® utilizes sophisticated depth control, eye tracking, and semi-automation for superior safety, precision, and efficiency.
NOTE: The VisioLite® Er;YAG Ophthalmic Laser is has 510K FDA clearance for the ophthalmic soft tissue around the eye and the orbit.however, it is not available for sale or use in the United States.
Note: LaserACE® is not yet FDA approved or available in the United States. It is currently in clinical trials only in select areas outside of the United States.
Ace Vision Group, Inc. 39655 Eureka Dr, Newark, CA 94560 Telephone: 234-738-4074 234-738-4074
Ace Vision See Life NaturallyTM, LaserACE® and VisioLite® are registered trademarks of Ace Vision Group, Inc. All rights reserved. 2008-2020.